Core Insights - The company reported third-quarter revenue of 81.1368 million yuan, representing a year-on-year increase of 21.80% [1] - Net profit for the third quarter was 1.0874 million yuan, showing a significant decline of 79.36% [1] - For the first three quarters, the company achieved revenue of 226 million yuan, which is a year-on-year growth of 15.61% [1] - Net profit for the first three quarters was 348,000 yuan, reflecting a drastic decrease of 97.24% [1]

证券日报网讯 10月13日晚间，康众医疗发布公告称，2025年8月15日，公司召开了第三届董事会第十次 （临时）会议，审议通过了《关于公司对外投资暨关联交易的议案》，公司拟使用自有资金2，000.00 万元人民币以增资形式参股上海仁筵信息科技有限公司（简称"仁筵信息"或"标的公司"），对应标的公 司新增注册资本24.1476万元，本次增资完成后，公司将持有仁筵信息6.67%股权。截至本公告披露日， 公司已向仁筵信息支付第一笔增资款，仁筵信息已完成相关事项的工商变更登记手续并取得更新后的营 业执照。 （文章来源：证券日报） ...

证券代码：688607 证券简称：康众医疗 公告编号：2025-039 江苏康众数字医疗科技股份有限公司 关于对外投资暨关联交易进展的公告 2025 年 8 月 15 日，江苏康众数字医疗科技股份有限公司（以下简称"康众 医疗"或"公司"）召开了第三届董事会第十次（临时）会议，审议通过了《关 于公司对外投资暨关联交易的议案》，公司拟使用自有资金 2,000.00 万元人民币 以增资形式参股上海仁筵信息科技有限公司（以下简称"仁筵信息"或"标的公 司"），对应标的公司新增注册资本 24.1476 万元，本次增资完成后，公司将持 有仁筵信息 6.67%股权。具体内容详见公司 2025 年 8 月 16 日披露于上海证券交 易所官网（www.sse.com.cn）的《关于对外投资暨关联交易的公告》（公告编号： 2025-032）。 二、对外投资暨关联交易进展情况 截至本公告披露日，公司已向仁筵信息支付第一笔增资款，仁筵信息已完成 相关事项的工商变更登记手续并取得更新后的营业执照。本次变更登记完成后具 体持股情况如下： | 单位：元/人民币 | | --- | | 股东姓名 | 认缴注册资本 | 持股比例 | | - ...

长川科技涨超7%，续创历史新高；英集芯、盛美上海、京仪装备、正帆科技、中微公司等跟涨。 (本文来自第一财经) ...

Group 1 - The Shanghai Stock Exchange's Sci-Tech Innovation Board semiconductor materials and equipment index fell by 1.62% as of September 25, 2025, with mixed performance among constituent stocks [1] - The Sci-Tech Semiconductor ETF (588170) decreased by 1.75%, with the latest price at 1.46 yuan, while its trading volume was active with a turnover of 18.85% and a total transaction value of 267 million yuan [1] - The latest scale of the Sci-Tech Semiconductor ETF reached a new high of 1.43 billion yuan, with the number of shares also hitting a record of 967 million [1] Group 2 - According to data from SEMI, global silicon wafer shipments in Q2 2025 reached 3.327 billion square inches, marking four consecutive quarters of year-on-year growth and the highest level since Q3 2023 [2] - The semiconductor equipment and materials industry is a key area for domestic substitution, benefiting from the expansion of semiconductor demand driven by the AI revolution and advancements in lithography technology [2] - The Sci-Tech Semiconductor ETF (588170) and its linked funds focus on semiconductor equipment (59%) and materials (25%), indicating a strong emphasis on the upstream semiconductor sector [2]

Group 1 - The semiconductor sector opened lower on September 25, with several companies experiencing significant declines [1] - Companies such as Deminli, Jiangbolong, Baiwei Storage, Jingyi Equipment, and Shengmei Shanghai all fell by over 3% [1]

Group 1 - The semiconductor sector continues to experience significant growth, with equipment-related stocks leading the surge [1] - Companies such as ShenGong Co. and Jiangfeng Electronics have reached a 20% limit-up, indicating strong market performance [1] - Other notable performers include Shengmei Shanghai and Weidao Nano, which have seen increases of over 10%, along with Beifang Huachuang, Jingyi Equipment, and Huahai Qingke, which are among the top gainers [1]

证券代码：688607 证券简称：康众医疗 公告编号：2025-038 江苏康众数字医疗科技股份有限公司 关于诉讼进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、本次诉讼的基本情况 公司于 2025 年 6 月 30 日就公司与合肥登特菲医疗设备有限公司（以下简称 "登特菲"或"被告"）之间《产品销售合同》《销售订单》之货款纠纷向苏州 工业园区人民法院提起诉讼，并收到受理法院出具的《受理案件通知书》（案号： (2025)苏 0591 民初 14893 号）。具体内容详见公司于 2025 年 7 月 2 日在上海证 券交易所（www.sse.com.cn）披露的《关于公司提起诉讼的公告》（公告编号： 2025-026）。 二、本次诉讼进展情况 案件所处的诉讼阶段：一审已判决，案件已审理终结 上市公司所处的当事人地位：原告 涉案金额：截至本公告披露日，本次案件审理判决的到期货款及逾期付 款违约金合计 15,939,541.72 元，由公司承担的案件受理费、保全费 3,299 元等其他费用等。 对 ...

证券代码：688607 证券简称：康众医疗 公告编号：2025-037 江苏康众数字医疗科技股份有限公司 关于参加 2025 年半年度科创板医疗器械及医疗设备 行业集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 江苏康众数字医疗科技股份有限公司（以下简称"公司"）于 2025 年 8 月 23 日披露了《2025 年半年度报告》。为加强与投资者的深入交流，使投资者更 加全面、深入地了解公司 2025 年半年度经营成果、财务状况，公司拟以网络文 字互动方式参加 2025 年半年度科创板医疗器械及医疗设备行业集体业绩说明 会，欢迎广大投资者积极参与。公司现就 2025 年半年度科创板医疗器械及医疗 设备行业集体业绩说明会提前向广大投资者征集相关问题，广泛听取投资者的意 见和建议。 一、说明会类型 公司董事长、总经理 JIANQIANG LIU（刘建强）先生，财务总监张萍女士， 董事会秘书尹晟先生，独立董事程星宝先生（如有特殊情况，参会人员可能进行 调整）。 四、投资者参加方式 1.投资者可 ...

Group 1 - The medical device sector experienced a decline of 1.78% on September 2, with Jimin Health leading the losses [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] - Notable gainers in the medical device sector included Wende Biological, which rose by 7.61% to a closing price of 25.58, and Jinhao Medical, which increased by 6.66% to 29.48 [1] Group 2 - Jimin Health saw a significant drop of 10.02%, closing at 11.40, with a trading volume of 1.0859 million shares and a transaction value of 1.331 billion [2] - Other notable decliners included Rejing Biological, which fell by 8.72% to 186.79, and Yikang Haosheng, which decreased by 7.71% to 34.24 [2] - The medical device sector experienced a net outflow of 1.23 billion from major funds, while retail investors contributed a net inflow of 1.011 billion [2]